PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Hypertension Research10.1038/s41440-019-0244-42019426817-824Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronismMinoru Satoh, Tatsuya Maruhashi, Yuichi Yoshida, Hirotaka Shibatahttp://www.nature.com/articles/s41440-019-0244-4.pdf, http://www.nature.com/articles/s41440-019-0244-4, http://www.nature.com/articles/s41440-019-0244-4.pdf
Endocrinology and Metabolism10.3803/enm.2020.7972020354838-846Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary AldosteronismYu-Fang Lin, Kang-Yung Peng, Chia-Hui Chang, Ya-Hui Hu, Vin-Cent Wu, Shiu-Dong Chung, http://e-enm.org/upload/pdf/enm-2020-797.pdf, http://e-enm.org/journal/view.php?doi=10.3803/EnM.2020.797, http://e-enm.org/upload/pdf/enm-2020-797.pdf
Journal of Psychiatric Research10.1016/j.jpsychires.2021.02.0642021137376-382Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxietyHarald Murck, Christian Adolf, Anna Schneider, Lena Schlageter, Daniel Heinrich, Katrin Ritzel, Lisa Sturm, Marcus Quinkler, Felix Beuschlein, Martin Reincke, Heike Künzelhttps://api.elsevier.com/content/article/PII:S0022395621001436?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022395621001436?httpAccept=text/plain
Journal of the Endocrine Society10.1210/jendso/bvaa046.139920204Supplement_1SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary AldosteronismYuta Tezuka, Adina Turcuhttp://academic.oup.com/jes/article-pdf/4/Supplement_1/SAT-564/33188081/bvaa046.1399.pdf, http://academic.oup.com/jes/article-pdf/4/Supplement_1/SAT-564/33188081/bvaa046.1399.pdf
The Journal of Clinical Endocrinology & Metabolism10.1210/clinem/dgab71920211072e896-e897Response to Letter to the Editor from Rossi and Rossitto: “Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism”Silvia Monticone, Franco Veglio, Paolo Mulaterohttp://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgab719/40664750/dgab719.pdf, https://academic.oup.com/jcem/article-pdf/107/2/e896/42224952/dgab719.pdf, https://academic.oup.com/jcem/article-pdf/107/2/e896/42224952/dgab719.pdf
The Journal of Clinical Endocrinology & Metabolism10.1210/clinem/dgab71720211072e892-e893Letter to the Editor From Paolo Rossi and Rossitto: “Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism”Gian Paolo Rossi, Giacomo Rossittohttp://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgab717/40664663/dgab717.pdf, https://academic.oup.com/jcem/article-pdf/107/2/e892/42224873/dgab717.pdf, https://academic.oup.com/jcem/article-pdf/107/2/e892/42224873/dgab717.pdf
Hormones10.1007/s42000-019-00167-92019192223-232Salt intake in mineralocorticoid receptor antagonist-treated primary aldosteronism: foe or ally?Stelios Fountoulakis, Labrini Papanastasiou, Nikos Voulgaris, Theodora Kounadi, Athina Markou, George P. Chrousos, George Piaditishttp://link.springer.com/content/pdf/10.1007/s42000-019-00167-9.pdf, http://link.springer.com/article/10.1007/s42000-019-00167-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s42000-019-00167-9.pdf
The Journal of Clinical Endocrinology & Metabolism10.1210/clinem/dgab29020211069e3655-e3664Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary AldosteronismAlessio Pecori, Fabrizio Buffolo, Jacopo Burrello, Giulio Mengozzi, Francesca Rumbolo, Valeria Avataneo, Antonio D’Avolio, Franco Rabbia, Chiara Bertello, Franco Veglio, Paolo Mulatero, Silvia Monticonehttp://academic.oup.com/jcem/advance-article-pdf/doi/10.1210/clinem/dgab290/38489098/dgab290.pdf, https://academic.oup.com/jcem/article-pdf/106/9/e3655/41379349/dgab290.pdf, https://academic.oup.com/jcem/article-pdf/106/9/e3655/41379349/dgab290.pdf
Metabolism10.1016/j.metabol.2012.08.0112013623386-391Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult malesAlexander W. Krug, Lissy Stelzner, Ajaykumar D. Rao, Andrew H. Lichtman, Gordon H. Williams, Gail K. Adlerhttps://api.elsevier.com/content/article/PII:S0026049512003150?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0026049512003150?httpAccept=text/plain
Journal of the Endocrine Society10.1210/jendso/bvaa046.24820204Supplement_1SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism ScreeningYuta Tezuka, Adina Turcuhttp://academic.oup.com/jes/article-pdf/4/Supplement_1/SAT-561/33188891/bvaa046.248.pdf, http://academic.oup.com/jes/article-pdf/4/Supplement_1/SAT-561/33188891/bvaa046.248.pdf